Medicine recalls
|
| |
| Canada: Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets |
| |
Health Canada announces that Jamp Pharma Corporation is recalling one lot of Jamp-Atorvastatin Calcium (lot number: D10776B) after one bottle labelled to contain 10 mg tablets of Jamp-Atorvastatin Calcium was found to contain 40 mg tablets of Jamp-Atorvastatin Calcium.
Pharmacists may not recognize the error and accidentally repackage and dispense bottles to patients that are labelled as 10 mg atorvastatin calcium tablets, but incorrectly contain 40 mg atorvastatin calcium tablets.
Both the 10 mg and 40 mg atorvastatin calcium tablets are similar-looking white and oval shaped tablets; however, the 10 mg tablets have a "10" marked on one side while the 40 mg tablets have a "40" marked on one side.
Taking too much atorvastatin calcium or more than the prescribed amount for a long period of time (i.e., taking 40 mg of atorvastatin calcium instead of 10 mg atorvastatin calcium) can increase the risk of serious adverse events, including muscle pain or muscle weakness (i.e., rhabdomyolysis, a rare but serious adverse event associated with statins).
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/recall-one-lot-jamp-atorvastatin-calcium-some-bottles-may-be-labelled-containing-10-mg
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Monday, Aug 29, 2022
Issued at HKT 13:00
|
| |
